V, L., & CF, B. (2013). On the choice of doses for phase III clinical trials. Statistics in medicine, 32(10), 1661. https://doi.org/10.1002/sim.5632
Chicago Style (17th ed.) CitationV, Lisovskaja, and Burman CF. "On the Choice of Doses for Phase III Clinical Trials." Statistics in Medicine 32, no. 10 (2013): 1661. https://doi.org/10.1002/sim.5632.
MLA (9th ed.) CitationV, Lisovskaja, and Burman CF. "On the Choice of Doses for Phase III Clinical Trials." Statistics in Medicine, vol. 32, no. 10, 2013, p. 1661, https://doi.org/10.1002/sim.5632.
Warning: These citations may not always be 100% accurate.